Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalized anxiety disorder: What are we missing?

Christer Allgulander1

  • 1Department of Clinical Neuroscience, Section of Psychiatry, Karolinska Institutet, Stockholm, Sweden. Christer.Allgulander@ki.se

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2022
Same author

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2022
Same author

Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression.

Molecular psychiatry·2019
Same author

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.

International clinical psychopharmacology·2019
Same author

Anxiety as a risk factor in cardiovascular disease.

Current opinion in psychiatry·2015
Same author

Anxiety and cardiovascular disease.

Modern trends in pharmacopsychiatry·2014

Generalized anxiety disorder (GAD) is common in primary care, yet underdiagnosed. Early detection and management through physician education and simple tools can improve patient quality of life.

Area of Science:

  • Psychiatry
  • Primary Care Medicine

Background:

  • Generalized anxiety disorder (GAD) is a prevalent condition in primary care settings.
  • Anxiety symptoms often manifest as physical ailments, prompting patient visits.
  • Despite high incidence, GAD is underdiagnosed in approximately 70% of cases.

Purpose of the Study:

  • To emphasize the critical need for early detection and management of GAD in primary care.
  • To explore strategies for improving GAD identification and treatment.

Main Methods:

  • The abstract discusses the need for physician education programs.
  • It highlights the potential utility of simple diagnostic tools for GAD detection.
  • It calls for more long-term data, including genetic and ethnic influences.

Related Experiment Videos

Main Results:

  • Only 30% of GAD sufferers are currently diagnosed.
  • Few diagnosed patients receive medication or psychiatric referral.
  • Early diagnosis and treatment are crucial for reducing patient burden.

Conclusions:

  • Improving GAD diagnosis rates requires enhanced physician education and accessible diagnostic tools.
  • Further research into long-term data, ethnicity, and genetics is needed for effective GAD management.
  • Early intervention in GAD significantly improves patient quality of life.